View Entire Collection
By Clinical Topic
By State Requirement
Diabetes – Summer 2012
Future of Nursing Initiative
Heart Failure - Fall 2011
Influenza - Winter 2011
Nursing Ethics - Fall 2011
Trauma - Fall 2010
Traumatic Brain Injury - Fall 2010
Fluids & Electrolytes
For the first time, scientists have grown human heart valves from stem cells taken from amniotic fluid. This research suggests that someday, patients with heart defects may be able to grow their own replacement valves.
Through amniocentesis, scientists collected amniotic fluid and isolated fetal stem cells from it. They cultured the fluid in a lab dish, then placed it in a mold. Twelve heart valves grew in 4 to 6 weeks. Tests indicated that the valves functioned normally.
Researchers hope this biotechnology can be developed to cure infants with congenital heart defects, which can be detected by ultrasound during pregnancy. Ideally, new valves would be cultivated in the lab while the pregnancy progresses and be ready to implant at birth. However, implanting tissue-engineered heart valves in people is probably years away.
A report on this promising research was given at an American Heart Association conference in Chicago, Ill., last November.
Sign up for our free enewsletters to stay up-to-date in your area of practice - or take a look at an archive of prior issues
Join our CESaver program to earn up to 100 contact hours for only $34.95
Explore a world of online resources
Back to Top